Project Grant HT94252310701
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$819K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Johns Hopkins University was awarded a $1,965,000 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2022 through July 2025 to develop a pharmacokinetic and pharmacodynamic immunocompromised mouse model of the human tick-borne disease Babesia microti. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
The Department of the Army Medical Command awarded The Johns Hopkins University a $814,065 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from December 1, 2024 to November 30, 2026, will fund research on "MECHANISMS OF IRISIN-INDUCED COGNITIVE BENEFIT IN PD." As a leading academic research institution, The Johns Hopkins University will leverage its expertise in biomedical research,...
The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $621,011.00 to The Johns Hopkins University to conduct research targeting sensory neurons via anti-CGRP therapies in osteosarcoma. The award period runs from Jul 1, 2025 to Jun 30, 2027. As a leading research institution, The Johns Hopkins University has a strong track record of supporting critical medical research initiatives for...
The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...
This $1,473,750 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports The Johns Hopkins University's research study on "The Immunomodulatory Impact of Chemotherapy When Combined with PD-1 Blockade in Resectable Lung Cancer." The 3-year grant, running from September 1, 2024 to August 31, 2027, aims to investigate innovative immunological interventions for treating lung cancer in military service...
The U.S. Department of the Army Medical Command awarded a $853,312 Project Grant to The Johns Hopkins University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant is for a project titled "Detection of Pulmonary Stromal Premetastatic Niches for Early Monitoring of Post-Surgery Metastatic Risk", with a performance period from Sep 1, 2024 to Aug 31, 2026. The project aims to conduct advanced biomedical research to transform healthcare for...